Recognition of tumor cells by the innate immune system (Q34167935)

31 July 2017

1 reference

title

Recognition of tumor cells by the innate immune system (English)

1 reference

31 July 2017

Soloski MJ

1

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Current Opinion in Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

154-162

1 reference

Regulation of immune responses through inhibitory receptors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Immune inhibitory receptors

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Natural killer cells: from no receptors to too many

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Natural killer cell receptors

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The mouse major histocompatibility complex: some assembly required.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Natural killer cell activation and inhibition by receptors for MHC class I.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

A disulfide-linked natural killer cell receptor dimer has higher affinity for HLA-C than wild-type monomer

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The central role of CD4( ) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The Qa-1b molecule binds to a large subpopulation of murine NK cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The Ly-49D receptor activates murine natural killer cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Nonstochastic coexpression of activation receptors on murine natural killer cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Genetic control of natural killing and in vivo tumor elimination by the Chok locus

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d).

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Human CD8 T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

KIR expression on self-reactive CD8 T cells is controlled by T-cell receptor engagement

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Impaired NK1 T cell development and early IL-4 production in CD1-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56 NK cells in vitro

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

In vivo natural killer cell activities revealed by natural killer cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(00)00198-9

7 January 2021

10.1016/S0952-7915(00)00198-9

Identifiers

DOI

1 reference

31 July 2017

1 reference